Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 1
2006 7
2007 5
2008 4
2009 5
2010 10
2011 19
2012 16
2013 16
2014 25
2015 27
2016 17
2017 30
2018 37
2019 42
2020 49
2021 61
2022 62
2023 58
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Results by year

Filters applied: . Clear all
Page 1
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation.
Wang Y, Zhang L, Huang T, Wu GR, Zhou Q, Wang FX, Chen LM, Sun F, Lv Y, Xiong F, Zhang S, Yu Q, Yang P, Gu W, Xu Y, Zhao J, Zhang H, Xiong W, Wang CY. Wang Y, et al. Among authors: xiong f. Eur Respir J. 2022 Sep 29;60(3):2003697. doi: 10.1183/13993003.03697-2020. Print 2022 Sep. Eur Respir J. 2022. PMID: 35086828 Free PMC article.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. Diabetes Care. 2022. PMID: 35061867 Free PMC article. Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Sucrose transporter in rice.
Wu Y, Fang W, Peng W, Jiang M, Chen G, Xiong F. Wu Y, et al. Among authors: xiong f. Plant Signal Behav. 2021 Nov 2;16(11):1952373. doi: 10.1080/15592324.2021.1952373. Epub 2021 Jul 16. Plant Signal Behav. 2021. PMID: 34269147 Free PMC article. Review.
The treatment of paraprotein-related kidney disease.
Hutchison CA, Xiong F, Mollee P. Hutchison CA, et al. Among authors: xiong f. Curr Opin Nephrol Hypertens. 2017 Nov;26(6):477-483. doi: 10.1097/MNH.0000000000000369. Curr Opin Nephrol Hypertens. 2017. PMID: 28885307 Review.
465 results